Plunkett Research Online: Galapagos NV

GALAPAGOS NV (GLPGF:GREY) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Galapagos NV is an integrated biopharmaceutical company that discovers, develops and commercializes medicines with novel modes of action, addressing disease areas of high unmet medical need. The company’s pipeline comprises programs ranging from discovery to Phase 3 clinical trials in inflammation,.....



Galapagos NV
Ticker: GLPGF
Exchange: GREY
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 32 15342900
Fax: 32 15342901
Address: Generaal De Wittelaan L11 A3
Mechelen, 2800 Belgium

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Biotechnology Research Services
Biopharmaceuticals
Drug Development
Drug Commercialization
Clinical Testing
Contacts Description

Onno van de Stolpe CEO
Michele Manto CCO
See More
Galapagos NV is an integrated biopharmaceutical company that discovers, develops and commercializes medicines with novel modes of action, addressing disease areas of high unmet medical need. The company’s pipeline comprises programs ranging from discovery to Phase 3 clinical trials in inflammation,.....See More See More

Auditor: Deloitte Bedrijfsrevisoren / Reviseurs d'Entreprises
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016 2015
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Gilead Sciences Inc
Filgotinib
GLPG1205
GLPG4716
Toledo-GLPG3970
Name Title Salary (EUR) Bonus (EUR)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: